[go: up one dir, main page]

NO20065836L - Linezolidkrystallform - Google Patents

Linezolidkrystallform

Info

Publication number
NO20065836L
NO20065836L NO20065836A NO20065836A NO20065836L NO 20065836 L NO20065836 L NO 20065836L NO 20065836 A NO20065836 A NO 20065836A NO 20065836 A NO20065836 A NO 20065836A NO 20065836 L NO20065836 L NO 20065836L
Authority
NO
Norway
Prior art keywords
linezolidkrystallform
linezohd
useful
active ingredient
crystal form
Prior art date
Application number
NO20065836A
Other languages
English (en)
Inventor
Michael S Bergren
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22658183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20065836(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO20065836L publication Critical patent/NO20065836L/no
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Oppfinnelsen er en ny krystallform av en kjent forbindelse, linezohd, som er anvendbar som et antibakterielt virkestoff.
NO20065836A 2000-02-02 2006-12-15 Linezolidkrystallform NO20065836L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17983700P 2000-02-02 2000-02-02
PCT/US2001/000657 WO2001057035A1 (en) 2000-02-02 2001-01-29 Linezolid-crystal form ii

Publications (1)

Publication Number Publication Date
NO20065836L true NO20065836L (no) 2002-08-01

Family

ID=22658183

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20023654A NO323459B1 (no) 2000-02-02 2002-08-01 (S)-N[[3-[3-fluor-4-(morfolinyl)fenyl]-2-okso-5-oksazolidinyl]metyl]acetamid ,krystall form II
NO20065836A NO20065836L (no) 2000-02-02 2006-12-15 Linezolidkrystallform

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20023654A NO323459B1 (no) 2000-02-02 2002-08-01 (S)-N[[3-[3-fluor-4-(morfolinyl)fenyl]-2-okso-5-oksazolidinyl]metyl]acetamid ,krystall form II

Country Status (30)

Country Link
EP (1) EP1255754B1 (no)
JP (1) JP5235256B2 (no)
KR (3) KR20080044358A (no)
CN (1) CN1221547C (no)
AR (1) AR027261A1 (no)
AT (1) ATE297920T1 (no)
AU (1) AU782138B2 (no)
BR (1) BR0107667A (no)
CA (1) CA2395603C (no)
CO (1) CO5261555A1 (no)
CZ (1) CZ302292B6 (no)
DE (1) DE60111497T2 (no)
DK (1) DK1255754T3 (no)
EA (1) EA004434B1 (no)
EE (1) EE05197B1 (no)
ES (1) ES2242728T3 (no)
HU (1) HUP0301076A3 (no)
IL (1) IL151010A0 (no)
MX (1) MXPA02007471A (no)
MY (1) MY122829A (no)
NO (2) NO323459B1 (no)
NZ (1) NZ520541A (no)
PE (1) PE20011086A1 (no)
PL (1) PL356433A1 (no)
PT (1) PT1255754E (no)
SI (1) SI1255754T1 (no)
SK (1) SK287025B6 (no)
TW (1) TWI297687B (no)
WO (1) WO2001057035A1 (no)
ZA (1) ZA200205162B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100490643B1 (ko) * 2002-10-29 2005-05-19 한국과학기술연구원 새로운 메틸리덴 피페리딘일 옥사졸리딘온 유도체 및이들의 제조방법
US7714128B2 (en) 2003-10-16 2010-05-11 Symed Labs Limited Crystalline form of linezolid
PL1737850T3 (pl) 2004-04-19 2008-02-29 Symed Labs Ltd Nowy sposób wytwarzania linezolidu i związków pokrewnych
WO2006004922A1 (en) * 2004-06-29 2006-01-12 Teva Pharmaceutical Industries Ltd. Crystalline form iv of linezolid
WO2006110155A1 (en) * 2004-06-29 2006-10-19 Teva Pharmaceutical Industries Ltd Solid forms of linezolid and processes for preparation thereof
EP1866295A2 (en) * 2005-02-24 2007-12-19 Teva Pharmaceutical Industries Ltd Processes for the preparation of linezolid intermediate
US20070112057A1 (en) * 2005-06-22 2007-05-17 Santiago Ini Polymorphic forms of tegaserod maleate
US20070020329A1 (en) * 2005-07-20 2007-01-25 Ruth Tenengauzer Methods of formulating linezolid
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
EP2099299A4 (en) * 2006-10-23 2011-11-30 Concert Pharmaceuticals Inc OXAZOLIDINONE DERIVATIVES AND METHOD FOR THEIR USE
WO2011050826A1 (en) 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
CA2798101A1 (en) 2010-04-30 2011-11-03 Indiana University Research And Technology Corporation Processes for preparing linezolid
EP2603506A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
CN103140487A (zh) 2010-08-11 2013-06-05 斯索恩有限公司 制备利奈唑胺的方法
CN103402990A (zh) * 2011-02-24 2013-11-20 李药业有限公司 无水利奈唑胺晶型-ii
EP2683696A1 (en) 2011-03-09 2014-01-15 Synthon BV Process for making crystalline form a of linezolid
CN102731341A (zh) * 2011-04-13 2012-10-17 上海医药工业研究院 用于制备利奈唑胺的中间体及其制备方法
CN105461648B (zh) * 2011-05-03 2018-01-12 江苏豪森药业集团有限公司 利奈唑胺的晶型及其制备方法
CN102399200B (zh) * 2011-12-14 2013-12-04 浙江新东港药业股份有限公司 一种利用悬浮结晶法制备利奈唑胺晶型ⅰ的方法
US20150025236A1 (en) 2012-01-24 2015-01-22 Jubilant Life Sciences Limited Process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
CN102643245A (zh) * 2012-04-10 2012-08-22 杭州华东医药集团生物工程研究所有限公司 一种利奈唑胺晶型及其制备方法
EP2917189B1 (en) 2012-11-09 2016-08-17 Synthon BV Process for making linezolid
US20190343761A1 (en) 2016-11-16 2019-11-14 Persica Pharmaceuticals Ltd. Antibiotic formulations for lower back pain
ES3034187T3 (en) * 2017-11-16 2025-08-13 Persica Pharmaceuticals Ltd Linezolid formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
CZ298060B6 (cs) * 1996-04-11 2007-06-06 Pharmacia & Upjohn Company Zpusob prípravy oxazolidinonu
TR200001199T2 (tr) * 1997-11-07 2000-08-21 Pharmacia & Upjohn Company Oksazolidinonların üretimi için işlem

Also Published As

Publication number Publication date
MY122829A (en) 2006-05-31
NZ520541A (en) 2004-02-27
ZA200205162B (en) 2003-09-29
CA2395603A1 (en) 2001-08-09
TWI297687B (en) 2008-06-11
HUP0301076A3 (en) 2004-06-28
EA004434B1 (ru) 2004-04-29
HUP0301076A2 (hu) 2003-08-28
SI1255754T1 (sl) 2005-12-31
EP1255754B1 (en) 2005-06-15
EA200200819A1 (ru) 2003-02-27
BR0107667A (pt) 2002-10-08
MXPA02007471A (es) 2002-12-13
EP1255754A1 (en) 2002-11-13
NO20023654D0 (no) 2002-08-01
JP2003522175A (ja) 2003-07-22
ES2242728T3 (es) 2005-11-16
CA2395603C (en) 2010-03-23
SK287025B6 (sk) 2009-10-07
CZ302292B6 (cs) 2011-02-09
NO323459B1 (no) 2007-05-14
DE60111497T2 (de) 2006-05-18
AU782138B2 (en) 2005-07-07
DK1255754T3 (da) 2005-08-22
PE20011086A1 (es) 2001-10-04
IL151010A0 (en) 2003-02-12
EE200200420A (et) 2003-12-15
EE05197B1 (et) 2009-08-17
NO20023654L (no) 2002-08-01
KR20070087178A (ko) 2007-08-27
KR100864745B1 (ko) 2008-10-22
JP5235256B2 (ja) 2013-07-10
PL356433A1 (en) 2004-06-28
AR027261A1 (es) 2003-03-19
SK9942002A3 (en) 2002-11-06
CN1394207A (zh) 2003-01-29
PT1255754E (pt) 2005-11-30
KR20080044358A (ko) 2008-05-20
CZ20022635A3 (cs) 2002-10-16
HK1051196A1 (en) 2003-07-25
CN1221547C (zh) 2005-10-05
AU3275501A (en) 2001-08-14
CO5261555A1 (es) 2003-03-31
DE60111497D1 (de) 2005-07-21
ATE297920T1 (de) 2005-07-15
WO2001057035A1 (en) 2001-08-09
KR20020072300A (ko) 2002-09-14
KR100781815B1 (ko) 2007-12-03

Similar Documents

Publication Publication Date Title
NO20065836L (no) Linezolidkrystallform
DK1385515T3 (da) Spiropyrazole forbindelser
NO20034289D0 (no) N-(2-aryletylbenzylaminer som antagonister av 5-HT6- reseptoren
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
DE60214392D1 (de) 1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen
NO20031001L (no) Polyarylkarboksamider nyttige som lipidsenkende midler
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
MXPA03009602A (es) Analogos de nociceptina.
NO20021409D0 (no) Hastighets-kontrollerte partikler
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
PT1289366E (pt) Combinacoes fungicidas de substancias activas
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
MY128164A (en) Compounds
TR199901017A2 (xx) B�cek ilac� terkibi.
DK1567013T3 (da) Acetaler som insektafvisende midler
PT1268475E (pt) Novos agentes bacterianos de benzosultam-oxazolidinona
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
BR0313400A (pt) N-aril-2-oxazolidinonas e seus derivados
NO20024679D0 (no) Krystallinsk farmasöytikum
DE50212676D1 (de) Exopolysaccharidproduktion
DK1301185T3 (da) Antihelmintika til forhindring af parasitære infektioner
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
SE0101762D0 (sv) New use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application